You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page.
Journal logo
Sections
Ask the Ethicist
At the Bench
Best Advances
Disease Mechanisms
Diversity
For Your Patients
In the Pipeline
Off the Clock
Neurotech
Letters to the Editor
Policy and Practice
Professionalism
The Science Explained
Wellness
Topics
Behavioral Neurology/Dementia
Cerebrovascular Disease
Child Neurology
Epilepsy
Genetics
Headache/Facial Pain
Movement Disorders
Multiple Sclerosis
Neurocritical Care
Neuroinfectious Disease
Neuromuscular
Neuro-oncology
Neuro-ophthalmology/Neuro-otology
Sleep Neurology
Sports Neurology/Concussion
At the Meetings
Meetings We Cover
Most Recent Meeting
About
About Neurology Today
Editorial Board
Subscription Services
Reprints
Rights and Permissions
About the AAN
American Academy of Neurology
Account
Register
Help
American Academy of Neurology
Login
Enter your Email address:
Wolters Kluwer Health may email you for journal alerts and information, but is committed to maintaining your privacy and will not share your personal information without your express consent. For more information, please refer to our Privacy Policy.
Subscribe to eTOC
Home
>
Issue Outline
May 20, 2010
Volume 10, Issue 10
Browse Issues
Policy and Practice
Policy and Practice
The Demise of Private Practice Neurology: Death by a Thousand Cuts
For Your Patients
For Your Patients
MUTATIONS FOUND IN 16% OF EARLY-ONSET PD
For Your Patients
Possible Role for Normal Prion Protein Identified in New Study — To Maintain Myelin that Insulates the Axon
For Your Patients
New Prion Disease Identified — Appears More Similar to Alzheimer Disease Than Scrapie
For Your Patients
Neurology Today Associate Editor Kenneth L. Tyler, MD, Comments:
For Your Patients
Relapse Patterns May Help Discern Guillain-Barré from Acute CIDP
For Your Patients
Black Stroke Patients Don't Receive as Much Evidence-Based Care
For Your Patients
Study Suggests tPA is ‘Safe’ for Ischemic Stroke False Alarms
For Your Patients
The Mysteries of Memory Unraveled
At the Meetings
At the Meetings
Simple Test May Help Assess Concussion in Athletes
At the Meetings
Preliminary Evidence Shows IVIG Slows Brain Atrophy and Cognitive Decline in Alzheimer Disease
At the Meetings
Reduced Thalamic and Corpus Callosum Areas Found to Correlate with Cognitive Impairment in Childhood-Onset MS
At the Meetings
Evidence Points to Amyloid Beta as the Key to Alzheimer Disease
At the Meetings
Fingolimod Found to Significantly Reduce Inflammation in Brains of MS Patients with Relapsing-Remitting Disease
At the Meetings
For Relapsing MS Patients, Oral Adjunctive Teriflunoide Offers Additional Benefit Over Glatiramer on MRI Parameters
At the Meetings
Lessons Learned from Post-Marketing Experience with PML-Associated Natalizumab
Issue Cover
Editor's Pick Podcast
Back to Top